Join the Chronic Obstructive Pulmonary Disease group to help and get support from people like you.
Chronic Obstructive Pulmonary Disease News (Page 3)
Related terms: Chronic Obstructive Pulmonary Disease, Acute, Bronchitis, Chronic, Bronchitis with Airway Obstruction, Chronic Bronchitis, Chronic Obstructive Airway Disease, Chronic Obstructive Lung Disease, COPD, Acute, COPD, Maintenance, Emphysema, Chronic Obstructive Pulmonary Disease, Maintenance, COPD
Generic, Brand-Name Medication Similarly Effective for COPD
MONDAY, Aug. 7, 2023 – For patients with chronic obstructive pulmonary disease (COPD), generic and brand-name fluticasone-salmeterol are similarly effective and safe, according to a study published...
Millions of Smokers May Have a Tough-to-Diagnose Lung Disease
WEDNESDAY, Aug. 2, 2023 – Millions of American smokers suffer from a potentially serious lung disease that's not technically chronic obstructive pulmonary disease (COPD), a new study finds. They...
Fixed-Ratio Spirometry Underdiagnoses COPD in African Americans
WEDNESDAY, Aug. 2, 2023 – The fixed-ratio spirometric criteria for chronic obstructive pulmonary disorder (COPD) underdiagnoses potential COPD in African American patients, according to a study...
Race-Specific Approach to Spirometry Disadvantages Black Patients
WEDNESDAY, July 26, 2023 – A race-specific approach to spirometry interpretation results in a lower lung allocation score (LAS) for Black patients and a higher LAS for White patients, according to a...
FDA Approves Breztri Aerosphere (budesonide/glycopyrrolate/formoterol fumarate) for the Maintenance Treatment of COPD
24 July 2020 – AstraZeneca’s Breztri Aerosphere (budesonide/glycopyrrolate/formoterol fumarate) has been approved in the US for the maintenance treatment of patients with chronic obstructive p...
FDA Approves Duaklir Pressair (aclidinium bromide and formoterol fumarate) for Maintenance Treatment of Chronic Obstructive Pulmonary Disease
Oxford, UK – 1 April 2019: Circassia Pharmaceuticals plc (“Circassia” or “the Company”; LSE: CIR), a specialty pharmaceutical company focused on respiratory disease, today announces the US Food and Dr...
FDA Approves ProAir Digihaler (albuterol sulfate) as the First and Only Digital Inhaler with Built-In Sensors
JERUSALEM--(BUSINESS WIRE)--Dec 21, 2018--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that the U.S. Food and Drug Administration (FDA) has approved ProAir ® Digihaler™ (a...
FDA Approves Yupelri (revefenacin) for Chronic Obstructive Pulmonary Disease (COPD)
DUBLIN, Ireland, HERTFORDSHIRE, England and PITTSBURGH, Nov. 9, 2018 /PRNewswire/ – Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma") and Mylan N.V. (NASDAQ: MYL) ("Mylan") today...
Once-Daily Trelegy Ellipta Gains Expanded Indication in the US for the Treatment of Patients with COPD
24 April 2018 – GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced that the US Food and Drug Administration (FDA) has approved an expanded indication for Trelegy...
FDA Medwatch Alert: Long-Acting Beta agonists (LABAs) and Inhaled Corticosteroids (ICS): Drug Safety Communication - Boxed Warning About Asthma-Related Death Removed
ISSUE: FDA's most prominent warning, the Boxed Warning, about asthma-related death has been removed from the drug labels of medicines that contain both an ICS and LABA. A FDA review of four large...
Sunovion Receives FDA Approval for Lonhala Magnair (glycopyrrolate) Inhalation Solution to Treat COPD
MARLBOROUGH, Mass.--(BUSINESS WIRE) December 5, 2017 --Sunovion Pharmaceuticals Inc. (Sunovion) today announced that the U.S. Food and Drug Administration (FDA) approved the New Drug Application...
FDA Approves Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) for the Treatment of COPD
London UK – 18 September 2017 – GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced that the US Food and Drug Administration (FDA) has approved once-daily, single i...
Bevespi Aerosphere Approved by the FDA for Patients with COPD
25 April 2016 – AstraZeneca today announced that the US Food and Drug Administration has approved Bevespi Aerosphere (glycopyrrolate and formoterol fumarate) inhalation aerosol indicated for the...
FDA Approves Seebri Neohaler (glycopyrrolate) for COPD
EAST HANOVER, N.J., Oct. 29, 2015 Novartis announced today that the US Food and Drug Administration (FDA) has approved Seebri Neohaler (glycopyrrolate) inhalation powder 15.6 mcg as a stand-alone...
FDA Approves Utibron Neohaler (indacaterol/glycopyrrolate) for COPD
EAST HANOVER, N.J., Oct. 29, 2015 Novartis announced today that the US Food and Drug Administration (FDA) has approved the dual combination bronchodilator Utibron Neohaler...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related drug support groups
prednisone, albuterol, Symbicort, Trelegy Ellipta, montelukast, Anoro Ellipta